Amica Retiree Medical Trust Trims Stock Holdings in NIKE, Inc. (NYSE:NKE)

Amica Retiree Medical Trust cut its stake in shares of NIKE, Inc. (NYSE:NKE) by 8.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,444 shares of the footwear maker’s stock after selling 385 shares during the period. Amica Retiree Medical Trust’s holdings in NIKE were worth $336,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. AssuredPartners Investment Advisors LLC purchased a new stake in NIKE during the fourth quarter worth about $259,000. NEOS Investment Management LLC grew its stake in NIKE by 31.5% during the 4th quarter. NEOS Investment Management LLC now owns 72,809 shares of the footwear maker’s stock worth $5,509,000 after purchasing an additional 17,421 shares in the last quarter. UniSuper Management Pty Ltd grew its stake in NIKE by 11.7% during the 4th quarter. UniSuper Management Pty Ltd now owns 162,825 shares of the footwear maker’s stock worth $12,321,000 after purchasing an additional 17,052 shares in the last quarter. Moment Partners LLC purchased a new stake in NIKE during the 4th quarter worth about $213,000. Finally, Sava Infond d.o.o. acquired a new stake in NIKE in the 4th quarter valued at about $2,047,000. 64.25% of the stock is owned by hedge funds and other institutional investors.

NIKE Trading Down 1.2 %

Shares of NIKE stock opened at $65.76 on Thursday. The firm has a market cap of $97.26 billion, a price-to-earnings ratio of 20.29, a price-to-earnings-growth ratio of 2.52 and a beta of 1.02. NIKE, Inc. has a 52-week low of $64.95 and a 52-week high of $98.04. The company’s 50-day simple moving average is $74.42 and its 200-day simple moving average is $77.13. The company has a quick ratio of 1.51, a current ratio of 2.22 and a debt-to-equity ratio of 0.57.

NIKE (NYSE:NKE) last released its earnings results on Thursday, March 20th. The footwear maker reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.26. The company had revenue of $11.27 billion for the quarter, compared to analysts’ expectations of $11.02 billion. NIKE had a return on equity of 36.99% and a net margin of 9.98%. The firm’s quarterly revenue was down 9.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.98 EPS. As a group, equities research analysts anticipate that NIKE, Inc. will post 2.05 earnings per share for the current year.

NIKE Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 3rd will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.43%. The ex-dividend date is Monday, March 3rd. NIKE’s dividend payout ratio (DPR) is currently 53.16%.

Insiders Place Their Bets

In related news, Director John W. Rogers, Jr. purchased 2,500 shares of NIKE stock in a transaction dated Friday, December 27th. The stock was bought at an average cost of $76.65 per share, for a total transaction of $191,625.00. Following the transaction, the director now owns 34,403 shares in the company, valued at approximately $2,636,989.95. The trade was a 7.84 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Chairman Mark G. Parker sold 169,732 shares of NIKE stock in a transaction on Friday, February 14th. The stock was sold at an average price of $72.83, for a total value of $12,361,581.56. Following the transaction, the chairman now directly owns 896,632 shares of the company’s stock, valued at approximately $65,301,708.56. This represents a 15.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Cfra Research raised shares of NIKE to a “moderate buy” rating in a report on Friday, March 21st. Citigroup cut NIKE from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $102.00 to $72.00 in a research report on Friday, February 7th. BMO Capital Markets cut their target price on NIKE from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Friday, March 21st. Jefferies Financial Group raised NIKE from a “hold” rating to a “buy” rating and upped their price target for the company from $75.00 to $115.00 in a report on Monday, February 24th. Finally, China Renaissance assumed coverage on shares of NIKE in a report on Wednesday, March 19th. They set a “hold” rating on the stock. Fifteen research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $87.38.

NIKE Company Profile

NIKE, Inc, together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks.